There was no sign of his body rejecting the kidney, Tatsuo Kawai, MD, PhD, director of the Legorreta Center for Clinical Transplantation Tolerance at Boston-based Massachusetts General Hospital, said during a panel discussion, the Globe reported Nov. 14.
Mr. Slayman, 62, was discharged from the hospital April 3, 18 days after undergoing the procedure. He died 51 days after the surgery. At the time, Massachusetts General Hospital stated there was no indication his death was a result of the transplant.
After being discharged, Mr. Slayman was well enough to spend time with family and visit a shopping mall twice, the Globe reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
